 |
Market Research Report
Genome Editing/Genome Engineering |
||||||
| Published by | Global Industry Analysts, Inc. | Product code | 907184 | ||||
| Published | Content info | 148 Pages Delivery time: 1-2 business days |
|||||
| Price |
|
||||||
| Genome Editing/Genome Engineering | ||
| Published: July 1, 2020 | Content info: 148 Pages |
|
Global Genome Editing/Genome Engineering Market to Reach $10.3 Billion by 2027
Amid the COVID-19 crisis, the global market for Genome Editing/Genome Engineering estimated at US$4.1 Billion in the year 2020, is projected to reach a revised size of US$10.3 Billion by 2027, growing at a CAGR of 14% over the analysis period 2020-2027. CRISPR, one of the segments analyzed in the report, is projected to record a 14.8% CAGR and reach US$4.3 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the TALEN segment is readjusted to a revised 14.2% CAGR for the next 7-year period.
The U.S. Market is Estimated at $1.2 Billion, While China is Forecast to Grow at 13.4% CAGR
The Genome Editing/Genome Engineering market in the U.S. is estimated at US$1.2 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.8 Billion by the year 2027 trailing a CAGR of 13.4% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 12.5% and 11.8% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 10.1% CAGR.
ZFN Segment to Record 12.6% CAGR
In the global ZFN segment, USA, Canada, Japan, China and Europe will drive the 12.4% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$840.5 Million in the year 2020 will reach a projected size of US$1.9 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$1.2 Billion by the year 2027.We bring years of research experience to this 9th edition of our report. The 148-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.
Competitors identified in this market include, among others,
Global Genome Editing Market 2020-2024
Global Genome Editing/Genome Engineering Market Size study, By technology, By Product and Services, By Application, By End-user and Regional Forecasts 2020-2027
Genome Editing/Genome Engineering Market by Technology (CRISPR, TALEN, ZFN, Antisense), Product & Service, Application (Cell Line Engineering, Genetic Engineering, Diagnostics, Drug Discovery & Development), End-User & Region-Global Forecast to 2025
Global Genome Editing Market By Technique, By Applications, By Source, By End-User, By Region, Forecast & Opportunities, 2025
Genome Editing Services Market-Focus on CRISPR 2019-2030
Global Genome Editing Market - Size, Trends, Competitive Analysis, Market Share and Forecasts (2019-2026)
Genome Editing Market, By Technology (CRISPR/ Cas9, TALEN/Mega TALs, and ZFN), By Delivery method (Ex-vivo, In-vivo), By Application, By End Use, By Geography (NA, EU, APAC, and RoW) - Analysis, Share, Trends, Size, & Forecast From 2014 - 2025
Asia Pacific Genome Editing Market to 2025 - Regional Analysis and Forecasts by Technology, Application End User, and Country
Europe Genome Editing Market to 2025 - Regional Analysis and Forecasts by Technology, Application End User, and Country
North America Genome Editing Market to 2025 - Regional Analysis and Forecasts by Technology, Application End User, and Country
